0002101704-25-000001.txt : 20251219 0002101704-25-000001.hdr.sgml : 20251219 20251218180708 ACCESSION NUMBER: 0002101704-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251219 DATE AS OF CHANGE: 20251218 EFFECTIVENESS DATE: 20251219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amphix Bio, Inc. CENTRAL INDEX KEY: 0002101704 ORGANIZATION NAME: EIN: 842306362 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-567448 FILM NUMBER: 251584492 BUSINESS ADDRESS: STREET 1: 400 N. ABERDEEN ST. STREET 2: SUITE 900 CITY: CHICAGO STATE: IL ZIP: 60642 BUSINESS PHONE: 720-840-7327 MAIL ADDRESS: STREET 1: 400 N. ABERDEEN ST. STREET 2: SUITE 900 CITY: CHICAGO STATE: IL ZIP: 60642 D 1 primary_doc.xml X0708 D LIVE 0002101704 Amphix Bio, Inc. 400 N. ABERDEEN ST. SUITE 900 CHICAGO IL ILLINOIS 60642 720-840-7327 DELAWARE None None Corporation true Nicholas Sather 400 N. Aberdeen St. Suite 900 Chicago IL ILLINOIS 60642 Executive Officer Director Samuel Stupp 400 N. Aberdeen St. Suite 900 Chicago IL ILLINOIS 60642 Executive Officer Director Kok-Wai Wong 400 N. Aberdeen St. Suite 900 Chicago IL ILLINOIS 60642 Director John Potocsnak 400 N. Aberdeen St. Suite 900 Chicago IL ILLINOIS 60642 Director Stephen R Wilson 400 N. Aberdeen St. Suite 900 Chicago IL ILLINOIS 60642 Director Biotechnology Decline to Disclose 06b false 2025-12-04 false true false 0 12500000 10300000 2200000 false 9 0 0 0 false Amphix Bio, Inc. /Nicholas Sather/ Nicholas Sather CEO 2025-12-18